CergenX
CergenX is an AI-based invention in neonatal brain monitoring technology that identifies newborn infants who are at risk of brain injury.
Based based in European Union (EU), Europe, Middle East, and Africa (EMEA), CergenX works in artificial intelligence (ai), innovation management, neuroscience, founded in 2021.
Within the artificial intelligence (ai), innovation management, neuroscience space, the company focuses on its core offering rather than a broad product line.
The company is recorded as being based in European Union (EU), Europe, Middle East, and Africa (EMEA).
Its current recorded stage is Seed.
Its team size is recorded as c_00001_00010 employees.
Public records show total funding of about $2M.
| Sector | Artificial Intelligence (AI), Innovation Management, Neuroscience |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2021 |
| Employees | c_00001_00010 |
| Stage | seed |
| Total funding | $2,000,000 |
Website: www.cergenx.com
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account